Bioqual (Bioqual) FCF Margin % : 4.56% (As of May. 2018)

View and export this data going back to . Start your Free Trial

What is Bioqual FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bioqual's Free Cash Flow for the six months ended in May. 2018 was $1.64 Mil. Bioqual's Revenue for the six months ended in May. 2018 was $35.89 Mil. Therefore, Bioqual's FCF Margin % for the quarter that ended in May. 2018 was 4.56%.

As of today, Bioqual's current FCF Yield % is 0.00%.

The historical rank and industry rank for Bioqual's FCF Margin % or its related term are showing as below:

BIOQ' s FCF Margin % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 4.56
Current: 4.56

During the past 13 years, the highest FCF Margin % of Bioqual was 4.56%. The lowest was 0.00%. And the median was 0.00%.

BIOQ's FCF Margin % is ranked better than
68.92% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: -11.3 vs BIOQ: 4.56

Bioqual FCF Margin % Historical Data

The historical data trend for Bioqual's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioqual FCF Margin % Chart

Bioqual Annual Data

Trend

May01

May03

May04

May05

May06

May07

May10

May11

May17

May18

FCF Margin %

Get a 7-Day Free Trial

2.42

2.01

-0.77

12.71

4.56

Bioqual Semi-Annual Data
	May96	May97	May98	May99	May00	May01	May03	May04	May05	May06	May07	May10	May11	May17	May18
FCF Margin %	Get a 7-Day Free Trial										2.42	2.01	-0.77	12.71	4.56

Competitive Comparison of Bioqual's FCF Margin %

For the Diagnostics & Research subindustry, Bioqual's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioqual's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bioqual's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Bioqual's FCF Margin % falls into.

Bioqual FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Bioqual's FCF Margin for the fiscal year that ended in May. 2018 is calculated as

FCF Margin	=	Free Cash Flow (A: May. 2018 )	/	Revenue (A: May. 2018 )
	=	1.636	/	35.885
	=	4.56 %

Bioqual's FCF Margin for the quarter that ended in May. 2018 is calculated as

FCF Margin	=	Free Cash Flow (Q: May. 2018 )	/	Revenue (Q: May. 2018 )
	=	1.636	/	35.885
	=	4.56 %

Bioqual FCF Margin % Related Terms

Thank you for viewing the detailed overview of Bioqual's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioqual (Bioqual) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioqual Inc (OTCPK:BIOQ) » Definitions » FCF Margin %

Comparable Companies

MDXH PSNL VNRX PRE ENZ PRPH ACRS BNR DRIO AWH TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

N/A

Address

9600 Medical Center Drive, Suite 101, Rockville, MD, USA, 20850

Website

https://www.bioqual.com

Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.

Executives

Williams Frank E Jr

other: Communication, See Remarks

2789-B HARTLAND ROAD, FALLS CHURCH VA 22043

Bioqual (Bioqual) Headlines

No Headlines